Blood biochemical markers of bone turnover: Pre-analytical and technical aspects of sample collection and handling

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 5, 2012, Pages 771-789

  Lombardi, Giovanni ^a   Lanteri, Patrizia ^a   Colombini, Alessandra ^a   Banfi, Giuseppe ^a,b  

^a IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Biological variability; Bone turnover markers; Stability; Standardisation

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL CROSS LINKING TELOPEPTIDE OF TYPE I COLLAGEN; AMINO TERMINAL PROPEPTIDE OF TYPE I PROCOLLAGEN; BIOCHEMICAL BONE TURNOVER MARKER; BIOLOGICAL MARKER; CARBOXY TERMINAL CROSS LINKED TELOPEPTIDE OF TYPE I PROCOLLAGEN; CARBOXY TERMINAL CROSS LINKING TELOPEPTIDE OF TYPE I COLLAGEN; CARBOXY TERMINAL PROPEPTIDE OF TYPE I PROCOLLAGEN; DEOXYPYRIDINOLINE; GESTAGEN; ORAL CONTRACEPTIVE AGENT; OSTEOCALCIN; PROCOLLAGEN; PYRIDINOLINE; TARTRATE RESISTANT ACID PHOSPHATASE 5B; UNCLASSIFIED DRUG;

AGE; BLOOD SAMPLING; BLOOD STORAGE; BONE MASS; BONE METABOLISM; BONE MINERALIZATION; BONE TURNOVER; CIRCADIAN RHYTHM; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNICITY; EXERCISE; HUMAN; MENOPAUSE; MENSTRUAL CYCLE; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN PROCESSING; REVIEW; SYSTEMATIC ERROR;

ARTIFACTS; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; BLOOD SPECIMEN COLLECTION; BONE AND BONES; HUMANS;

EID: 84867749377     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2011-0614     Document Type: Review

References (166)

1. Lippi G, Guidi GC, Mattiuzzi C, Plebani M. Preanalytical variability: the dark side of the moon in laboratory testing. Clin Chem Lab Med 2006;44:358-65.
2. Wiwanitkit V. Types and frequency of preanalytical mistakes in the first Thai ISO 9002:1994 certified clinical laboratory, a 6-month monitoring. BMC Clin Pathol 2001;1:5.
3. Bonini P, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem 2002;48:691-8.
4. Simundic AM, Nikolac N, Vukasovic I, Vrkic N. The prevalence of preanalytical errors in a Croatian ISO 15189 accredited laboratory. Clin Chem Lab Med 2010;48:1009-14.
5. Lippi G, Chance JJ, Church S, Dazzi P, Fontana R, Giavarina D, et al. Preanalytical quality improvement: from dream to reality. Clin Chem Lab Med 2011;49:1113-26.
6. Hollensead SC, Lockwood WB, Elin RJ. Errors in pathology and laboratory medicine: consequences and prevention. J Surg Oncol 2004;88:161-81.
7. Howanitz PJ. Errors in laboratory medicine: practical lessons to improve patient safety. Arch Pathol Lab Med 2005;129:1252-61.
8. Lippi G, Salvagno GL, Montagnana M, Poli G, Guidi GC. Influence of centrifuge temperature on routine coagulation testing. Clin Chem 2006;52:537-8.
9. Lippi G, Salvagno GL, Solero GP, Franchini M, Guidi GC. Stability of blood cell counts, hematologic parameters and reticu-locytes indexes on the Advia A120 hematologic analyser. J Lab Clin Med 2005;146:333-40.
10. Vesper HW, Demers LM, Eastell R, Garnero P, Kleerekoper M, Robins SP, et al. Assessment and recommendations on factors contributing to preanalytical variability of urinary pyridinoline and deoxypyridinoline. Clin Chem 2002;48:220-35.
11. Veri A, D'Andrea MR, Bonginelli P, Gasparini G. Clinical usefulness of bisphosphonates in oncology: treatment of bone metasta-ses, antitumoral activity and effect on bone resorption markers. Int J Biol Markers 2007;22:24-33.
12. Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res 1996;11:1531-8.
13. Miller PD, Baran DT, Bilezikian JP, Greenspan SL, Lindsay R, Riggs BL, et al. Practical clinical application of biochemical markers of bone turnover: consensus of an expert panel. J Clin Densitom 1999;2:323-42.
14. Looker AC, Bauer DC, Chesnut CH 3rd, Gundberg CM, Hochberg MC, Klee G, et al. Clinical use of biochemical markers of bone remodeling: current status and future directions. Osteoporosis Int 2000;11:467-80.
15. Banfi G, Lombardi G, Colombini A, Lippi G. Bone metabolism markers in sports medicine. Sports Med 2010;40:697-714.
16. Seibel MJ. Biochemical markers of bone turnover. Part I: biochemistry and variability. Clin Biochem Rev 2005;26:97-122.
17. Phan TC, Xu J, Zheng MH. Interaction between osteoblast and osteoclast: impact in bone disease. Histol Histopathol 2004;19:1325-44.
18. Camozzi V, Tossi A, Simoni E, Pagani F, Francucci CM, Moro L. Role of biochemical markers of bone remodeling in clinical practice. J Endocrinol Invest 2007;30:13-7.
19. Glover SJ, Gall M, Schoenborn-Kellenberger O, Wagener M, Garnero P, Boonen S, et al. Establishing a reference interval for bone turnover markers in 637 healthy, young, premenopausal women from the United Kingdom, France, Belgium, and the United States. J Bone Miner Res 2009;24:389-97.
20. Merlini G, Blirup-Jensen S, Johnson AM, Sheldon J, Zegers I. Standardizing plasma protein measurements worldwide: a challenging enterprise. Clin Chem Lab Med 2010;48:1567-75.
21. Bergmann P, Body JJ, Boonen S, Boutsen Y, Devogelaer JP, Goemaere S, et al. Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club. Int J Clin Pract 2009;63:19-26.
22. Vasikaran S, Eastell R, Bruyere O, Foldes AJ, Garnero P, Griesmacher A, et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 2011;22:391-420.
23. Hannon R, Eastell R. Preanalytical variability of biochemical markers of bone turnover. Osteoporos Int 2000;11(Suppl 6):S30-44.
24. Bernardi D, Zaninotto M, Plebani M. Requirements for improving quality in the measurement of bone markers. Clin Chim Acta 2004;346:79-86.
25. Garnero P. Bone markers in osteoporosis. Curr Osteoporos Rep 2009;7:84-90.
26. Seibel MJ, Woitge HW. Basic principles and clinical applications of biochemical markers of bone metabolism: biochemical and technical aspects. J Clin Densitom 1999;2:299-321.
27. Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J. The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporos Int 2000;11(Suppl 6):S2-17.
28. Seibel M. Molecular markers of bone turnover: biochemical, technical and analytical aspects. Osteoporos Int 2000;6:S18-29.
29. Harris H. The human alkaline phosphatases: what we know and what we don't know. Clin Chim Acta 1990;186:133-50.
30. Magnusson P, Larsson L, Magnusson M, Davie MW, Sharp CA. Isoforms of bone alkaline phosphatase: characterisation and origin in human trabecular and cortical bone. J Bone Miner Res 1999;14:1926-33.
31. Epstein S. Serum and urinary markers of bone remodeling: assessment of bone turnover. Endocr Rev 1988;9:437-49.
32. Van Straalen JP, Sanders E, Prummel MF, Sanders GT. Bone-alkaline phosphatase as indicator of bone formation. Clin Chim Acta 1991;201:27-33.
33. Cavalier E, Rozet E, Carlisi A, Bekaert AC, Rousselle O, Hubert P, et al. Analytical validation of serum bone alkaline phosphatase (BAP OSTASE) on Liaison. Clin Chem Lab Med 2010;48:67-72.
34. Hauschka PV, Lian JB, Cole DE, Gundberg CM. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 1989;69:990-1047.
35. Poser JW, Esch FS, Ling NC, Price PA. Isolation and sequence of the vitamin K-dependent protein from human bone. Undercarboxylation of the first glutamic acid residue. J Biol Chem 1980;255:8685-91.
36. Brown JP, Delmas PD, Malaval L, Edouard C, Chapuy MC, Meunier PJ. Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet 1984;1:1091-3.
37. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007;130:456-69.
38. Lee NK, Karsenty G. Reciprocal regulation of bone and energy metabolism. Trends Endocrinol Metab 2008;19:161-6.
39. Takeda S, Karsenty G. Molecular bases of the sympathetic regulation of bone mass. Bone 2008;42:837-40.
40. Confavreux CB, Levine RL, Karsenty G. A paradigm of integra-tive physiology, the crosstalk between bone and energy metabolisms. Mol Cell Endocrinol 2009;310:21-9.
41. Ferron M, Wei J, Yoshizawa T, Ducy P, Karsenty G. An ELISA-based method to quantify osteocalcin carboxylation in mice. Biochem Biophys Res Commun 2010;397:691-6.
42. Bell NH. Assays for osteocalcin: all are not equal. J Lab Clin Med 1997;129:396-7.
43. Lee AJ, Hodges S, Eastell R. Measurement of osteocalcin. Ann Clin Biochem 2000;37(Pt 4):432-46.
44. Monaghan DA, Power MJ, Fottrell PF. Sandwich enzyme immu-noassay of osteocalcin in serum with use of an antibody against human osteocalcin. Clin Chem 1993;39:942-7.
45. Hosoda K, Eguchi H, Nakamoto T, Kubota T, Honda H, Jindai S, et al. Sandwich immunoassay for intact human osteocalcin. Clin Chem 1992;38:2233-8.
46. Bjarnason NH, Christiansen C. The influence of thinness and smoking on bone loss and response to hormone replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 2000;85:590-6.
47. Hassager C, Jensen LT, Johansen JS, Riis BJ, Melkko J, Podenphant J, et al. The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones. Metabolism 1991;40:205-8.
48. Eriksen EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphom-etry. J Bone Miner Res 1993;8:127-32.
49. Eyre DR, Dickson IR, Van Ness K. Collagen cross-linking in human bone and articular cartilage. Age-related changes in the content of mature hydroxypyridinium residues. Biochem J 1988;252:495-500.
50. Garnero P, Gineyts E, Arbault P, Christiansen C, Delmas PD. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J Bone Miner Res 1995;10:641-9.
51. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C. Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 1994;40:2022-5.
52. Melkko J, Niemi S, Risteli L, Risteli J. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 1990;36:1328-32.
53. Garnero P, Gineyts E, Riou JP, Delmas PD. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. J Clin Endocrinol Metab 1994;79:780-5.
54. Cloos PA, Fledelius C. Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: a biological clock of protein aging with clinical potential. Biochem J 2000;345(Pt 3):473-80.
55. Halleen JM, Alatalo SL, Suominen H, Cheng S, Janckila AJ, Vaananen HK. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption. J Bone Miner Res 2000;15:1337-45.
56. Yaziji H, Janckila AJ, Lear SC, Martin AW, Yam LT. Immuno-histochemical detection of tartrate-resistant acid phosphatase in non-hematopoietic human tissues. Am J Clin Pathol 1995;104:397-402.
57. Lomeo A, Bolner A. Stability of several biochemical markers of bone metabolism. Clin Chem 2000;46:1200-2.
58. Meddah B, Kamel S, Giroud C, Brazier M. Effects of ultraviolet light on free and peptide-bound pyridinoline and deoxy-pyridinoline cross-links. Protective effect of acid pH against photolytic degradation. J Photochem Photobiol B 2000;54:168-74.
59. Stokes FJ, Ivanov P, Bailey LM, Fraser WD. The effects of sampling procedures and storage conditions on short-term stability of blood-based biochemical markers of bone metabolism. Clin Chem 2011;57:138-40.
60. World Health Organization. Use of anticoagulants in diagnostic laboratory investigation and stability of blood, plasma or serum samples. Available at: http://whqlibdoc.who.int/hq/2002/WHO-DIL-LAB-99.1-Rev. 2.pdf. Accessed:15 January 2002.
61. Huber F, Traber L, Roth HJ, Heckel V, Schmidt-Gayk H. Markers of bone resorption-measurement in serum, plasma or urine? Clin Lab 2003;49:203-7.
62. Lippi G, Brocco G, Salvagno GL, Montagnana M, Guidi GC, Schmidt-Gayk H. Influence of the sample matrix on the stability of beta-CTX at room temperature for 24 and 48 hours. Clin Lab 2007;53:455-9.
63. Herrmann M, Pape G, Herrmann W. Measurement of serum beta-crosslaps is influenced by proteolytic conditions. Clin Chem Lab Med 2002;40:790-4.
64. Herrmann M, Pape G, Herrmann W. Stability of serum beta-crosslaps during storage: influence of pH and storage temperature. Clin Chem 2001;47:939-40.
65. Zwart SR, Wolf M, Rogers A, Rodgers S, Gillman PL, Hitchcox K, et al. Stability of analytes related to clinical chemistry and bone metabolism in blood specimens after delayed processing. Clin Biochem 2009;42:907-10.
66. Brandhorst G, Engelmayer J, Gotze S, Oellerich M, Von Ahsen N. Preanalytical effects of different lithium heparin plasma separation tubes in the routine clinical chemistry laboratory. Clin Chem Lab Med 2011;49:1473-7.
67. Clowes JA, Hannon RA, Yap TS, Hoyle NR, Blumsohn A, Eastell R. Effect of feeding on bone turnover markers and its impact on biological variability of measurements. Bone 2002;30:886-90.
68. Brown JP, Albert C, Nassar BA, Adachi JD, Cole D, Davison KS, et al. Bone turnover markers in the management of postmeno-pausal osteoporosis. Clin Biochem 2009;42:929-42.
69. Herrmann W, Obeid R, Schorr H, Hubner U, Geisel J, Sand-Hill M, et al. Enhanced bone metabolism in vegetarians-the role of vitamin B12 deficiency. Clin Chem Lab Med 2009;47:1381-7.
70. Guder W, Buttner J. [Clinical chemistry in laboratory medicine in Europe. The past, present, and future]. Klin Lab Diagn 1998;10:35-40.
71. Noonan K, Kalu ME, Holownia P, Burrin JM. Effect of different storage temperatures, sample collection procedures and immu-noassay methods on osteocalcin measurement. Eur J Clin Chem Clin Biochem 1996;34:841-4.
72. Banfi G, Daverio R. In vitro stability of osteocalcin. Clin Chem 1994;40:833-4.
73. Power MJ, O'Dwyer B, Breen E, Fottrell PF. Osteocalcin concentrations in plasma prepared with different anticoagulants. Clin Chem 1991;37:281-4.
74. Banfi G, Bauer K, Deom A, Fraser GC, Golf S, Haghemann P, et al. The quality of diagnostic samples. 2009; Available from: http://www. diagnosticsample.com/home.php3?lang=en.
75. Vasikaran S, Cooper C, Eastell R, Griesmacher A, Morris HA, Trenti T, et al. International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine Position on bone marker standards in osteoporosis. Clin Chem Lab Med 2011;49:1271-4.
76. Vasikaran SD, Morris HA, Cooper C, Kanis JA. Standardising biochemical assessment of bone turnover in osteoporosis. Clin Biochem 2011;44:1033-4.
77. Blumsohn A, Hannon RA, Eastell R. Apparent instability of osteocalcin in serum as measured with different commercially available immunoassays. Clin Chem 1995;41:318-9.
78. Baumgrass R, Daenzer M, Felsenberg D. Improved in vitro stability of serum osteocalcin by using a new commercially available antiproteolytic compound. Clin Chim Acta 1999;281:47-55.
79. Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 1994;79:1693-700.
80. Durham BH, Robinson J, Fraser WD. Differences in the stability of intact osteocalcin in serum, lithium heparin plasma and EDTA plasma. Ann Clin Biochem 1995;32(Pt 4):422-3.
81. Tarallo P, Balland M, Henny J. Effect of long-term storage on human plasma osteocalcin level. Clin Chim Acta 1992;208:237-9.
82. Schmidt-Gayk H, Spanuth E, Kotting J, Bartl R, Felsenberg D, Pfeilschifter J, et al. Performance evaluation of automated assays for beta-Cross Laps, N-MID-Osteocalcin and intact parathyroid hormone (BIOROSE Multicenter Study). Clin Chem Lab Med 2004;42:90-5.
83. Jensen JE, Sorensen HA, Kollerup G, Jensen LB, Sorensen OH. Biological variation of biochemical bone markers. Scand J Clin Lab Invest Suppl 1994;219:36-9.
84. Panteghini M, Pagani F. Biological variation in bone-derived biochemical markers in serum. Scand J Clin Lab Invest 1995;55:609-16.
85. Panteghini M. Variabilità analitica e biologica degli indi-catori biochimici di rimodellamento osseo. Ligand Assay 1998;3:176-8.
86. Hannon R, Blumsohn A, Naylor K, Eastell R. Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability. J Bone Miner Res 1998;13:1124-33.
87. Beck-Jensen JE, Kollerup G, Sorensen HA, Pors Nielsen S, Sorensen OH. A single measurement of biochemical markers of bone turnover has limited utility in the individual person. Scand J Clin Lab Invest 1997;57:351-9.
88. Lombardi G, Colombini A, Freschi M, Tavana R, Banfi G. Seasonal variation of bone turnover markers in top-level female skiers. Eur J Appl Physiol 2011;111:433-40.
89. Alvarez L, Ric Os C, Peris P, Gua Nabens N, Monegal A, Pons F, et al. Components of biological variation of biochemical markers of bone turnover in Paget's bone disease. Bone 2000;26:571-6.
90. Gardham C, Stevens PE, Delaney MP, Le Roux M, Coleman A, Lamb EJ. Variability of parathyroid hormone and other markers of bone mineral metabolism in patients receiving hemodialysis. Clin J Am Soc Nephrol 2010;5:1261-7.
91. Scariano JK, Garry PJ, Montoya GD, Wilson JM, Baumgartner RN. Critical differences in the serial measurement of three biochemical markers of bone turnover in the sera of pre-and post-menopausal women. Clin Biochem 2001;34:639-44.
92. Nguyen TV, Nelson AE, Howe CJ, Seibel MJ, Baxter RC, Handelsman DJ, et al. Within-subject variability and analytic imprecision of insulinlike growth factor axis and collagen markers: implications for clinical diagnosis and doping tests. Clin Chem 2008;54:1268-76.
93. Stevenson HP, Leslie H, Sheridan B. Intra-individual variation in serum type I procollagen carboxy-terminal propeptide and type I collagen carboxy-terminal cross-linked telopeptide concentrations. Ann Clin Biochem 1997;34(Pt 3):317-8.
94. Herrmann M, Seibel MJ. The amino-and carboxyterminal cross-linked telopeptides of collagen type I, NTX-I and CTX-I: a comparative review. Clin Chim Acta 2008;393:57-75.
95. Okabe R, Nakatsuka K, Inaba M, Miki T, Naka H, Masaki H, et al. Clinical evaluation of the Elecsys beta-Cross Laps serum assay, a new assay for degradation products of type I collagen C-tlopeptides. Clin Chem 2001;47:1410-4.
96. Delmas PD, Chatelain P, Malaval L, Bonne G. Serum bone GLA-protein in growth hormone deficient children. J Bone Miner Res 1986;1:333-8.
97. Bass S, Delmas PD, Pearce G, Hendrich E, Tabensky A, Seeman E. The differing tempo of growth in bone size, mass, and density in girls is region-specific. J Clin Invest 1999;104:795-804.
98. Blumsohn A, Hannon RA, Wrate R, Barton J, Al-Dehaimi AW, Colwell A, et al. Biochemical markers of bone turnover in girls during puberty. Clin Endocrinol (Oxf) 1994;40:663-70.
99. Mora S, Pitukcheewanont P, Kaufman FR, Nelson JC, Gilsanz V. Biochemical markers of bone turnover and the volume and the density of bone in children at different stages of sexual development. J Bone Miner Res 1999;14:1664-71.
100. Orwoll ES, Bell NH, Nanes MS, Flessland KA, Pettinger MB, Mallinak NJ, et al. Collagen N-telopeptide excretion in men: the effects of age and intrasubject variability. J Clin Endocrinol Metab 1998;83:3930-5.
101. Rauchenzauner M, Schmid A, Heinz-Erian P, Kapelari K, Falkensammer G, Griesmacher A, et al. Sex-and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years. J Clin Endocrinol Metab 2007;92:443-9.
102. Kruse K, Bartels H, Gunther H. Serum alkaline phosphatase isoenzymes in childhood. Eur J Pediatr 1977;126:53-9.
103. Statland BE, Nishi HH, Young DS. Serum alkaline phosphatase: total activity and isoenzyme determinations made by use of the centrifugal fast analyser. Clin Chem 1972;18:1468-74.
104. Schiele F, Henny J, Hitz J, Petitclerc C, Gueguen R, Siest G. Total bone and liver alkaline phosphatases in plasma: biological variations and reference limits. Clin Chem 1983;29:634-41.
105. Alberti C, Chevenne D, Mercat I, Josserand E, Armoogum-Boizeau P, Tichet J, et al. Serum concentrations of insulin-like growth factor (IGF)-1 and IGF binding protein-3 (IGFBP-3), IGF-1/IGFBP-3 ratio, and markers of bone turnover: reference values for French children and adolescents and z-score comparability with other references. Clin Chem 2011;57:1424-35.
106. Petit Clerc C. Quantitative fractionation of alkaline phosphatase isoenzymes according to their thermostability. Clin Chem 1976;22:42-8.
107. Plomteux G, Reginster N. Measurement of the hepatic, intestinal and bony fractions of the serum alkaline phosphatase. Ann Biol Clin (Paris) 1980;38:215-22.
108. Whitaker KB, Whitby LG, Moss DW. Activities of bone and liver alkaline phosphatases in serum in health and disease. Clin Chim Acta 1977;80:209-20.
109. Crilly RG, Jones MM, Horsman A, Nordin BE. Rise in plasma alkaline phosphatase at the menopause. Clin Sci 1980;58:341-2.
110. Tarallo P, Henny J, Fournier B, Siest G. Plasma osteocalcin: biological variations and reference limits. Scand J Clin Lab Invest 1990;50:649-55.
111. Garnero P, Sornay-Rendu E, Delmas PD. Decreased bone turnover in oral contraceptive users. Bone 1995;16:499-503.
112. Schlemmer A, Hassager C, Risteli J, Risteli L, Jensen SB, Christiansen C. Possible variation in bone resorption during the normal menstrual cycle. Acta Endocrinol (Copenh) 1993;129:388-92.
113. Chiu KM, Ju J, Mayes D, Bacchetti P, Weitz S, Arnaud CD. Changes in bone resorption during the menstrual cycle. J Bone Miner Res 1999;14:609-15.
114. Zittermann A, Schwarz I, Scheld K, Sudhop T, Berthold HK, Von Bergmann K, et al. Physiologic fluctuations of serum estra-diol levels influence biochemical markers of bone resorption in young women. J Clin Endocrinol Metab 2000;85:95-101.
115. Gorai I, Chaki O, Nakayama M, Minaguchi H. Urinary biochemical markers for bone resorption during the menstrual cycle. Calcif Tissue Int 1995;57:100-4.
116. Gorai I, Taguchi Y, Chaki O, Kikuchi R, Nakayama M, Yang BC, et al. Serum soluble interleukin-6 receptor and biochemical markers of bone metabolism show significant variations during the menstrual cycle. J Clin Endocrinol Metab 1998;83:326-32.
117. Nielsen HK, Brixen K, Bouillon R, Mosekilde L. Changes in biochemical markers of osteoblastic activity during the menstrual cycle. J Clin Endocrinol Metab 1990;70:1431-7.
118. Hannon R, Eastell R. Preanalytical variability of biochemical markers of bone turnover. Osteoporos Int 2000;11(Suppl 6):S30-44.
119. Herrmann M, Seibel MJ. The effects of hormonal contraceptives on bone turnover markers and bone health. Clin Endocrinol (Oxf) 2010;72:571-83.
120. Lewis LL, Shaver JF, Woods NF, Lentz MJ, Cain KC, Hertig V, et al. Bone resorption levels by age and menopausal status in 5, 157 women. Menopause 2000;7:42-52.
121. Hassager C, Fabbri-Mabelli G, Christiansen C. The effect of the menopause and hormone replacement therapy on serum carboxyterminal propeptide of type I collagen. Osteoporos Int 1993;3:50-2.
122. Clemens JD, Herrick MV, Singer FR, Eyre DR. Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption. Clin Chem 1997;43:2058-63.
123. Rosenquist C, Fledelius C, Christgau S, Pedersen BJ, Bonde M, Qvist P, et al. Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen. Clin Chem 1998;44:2281-9.
124. Kushida K, Takahashi M, Kawana K, Inoue T. Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients. J Clin Endocrinol Metab 1995;80:2447-50.
125. Woitge HW, Seibel MJ, Ziegler R. Comparison of total and bone-specific alkaline phosphatase in patients with nonskel-etal disorder or metabolic bone diseases. Clin Chem 1996;42:1796-804.
126. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 1996;11:337-49.
127. Ebeling PR, Atley LM, Guthrie JR, Burger HG, Dennerstein L, Hopper JL, et al. Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab 1996;81:3366-71.
128. Bjarnason NH, Christiansen C. Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women. Bone 2000;26:561-9.
129. Khosla S, Atkinson EJ, Melton LJ 3rd, Riggs BL. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study. J Clin Endocrinol Metab 1997;82:1522-7.
130. Rogers A, Hannon RA, Eastell R. Biochemical markers as predictors of rates of bone loss after menopause. J Bone Miner Res 2000;15:1398-404.
131. Yasui T, Uemura H, Tomita J, Miyatani Y, Yamada M, Miura M, et al. Association of serum undercarboxylated osteocalcin with serum estradiol in pre-, peri-and early post-menopausal women. J Endocrinol Invest 2006;29:913-8.
132. Rosenbrock H, Seifert-Klauss V, Kaspar S, Busch R, Luppa PB. Changes of biochemical bone markers during the menopausal transition. Clin Chem Lab Med 2002;40:143-51.
133. Sowers MR, Greendale GA, Bondarenko I, Finkelstein JS, Cauley JA, Neer RM, et al. Endogenous hormones and bone turnover markers in pre-and perimenopausal women: SWAN. Osteoporos Int 2003;14:191-7.
134. Resch H, Pietschmann P, Kudlacek S, Woloszczuk W, Krexner E, Bernecker P, et al. Influence of sex and age on biochemical bone metabolism parameters. Miner Electrolyte Metab 1994;20:117-21.
135. Vanderschueren D, Gevers G, Raymaekers G, Devos P, Dequeker J. Sex-and age-related changes in bone and serum osteocalcin. Calcif Tissue Int 1990;46:179-82.
136. Duda RJ Jr, O'Brien JF, Katzmann JA, Peterson JM, Mann KG, Riggs BL. Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: effects of sex, age, and metabolic bone disease. J Clin Endocrinol Metab 1988;66:951-7.
137. Henry YM, Eastell R. Ethnic and gender differences in bone mineral density and bone turnover in young adults: effect of bone size. Osteoporos Int 2000;11:512-7.
138. Epstein S, Poser J, McClintock R, Johnston CC Jr, Bryce G, Hui S. Differences in serum bone GLA protein with age and sex. Lancet 1984;1:307-10.
139. Greenspan SL, Dresner-Pollak R, Parker RA, London D, Ferguson L. Diurnal variation of bone mineral turnover in elderly men and women. Calcif Tissue Int 1997;60:419-23.
140. Blumsohn A, Herrington K, Hannon RA, Shao P, Eyre DR, Eastell R. The effect of calcium supplementation on the cir-cadian rhythm of bone resorption. J Clin Endocrinol Metab 1994;79:730-5.
141. Eastell R, Simmons PS, Colwell A, Assiri AM, Burritt MF, Russell RG, et al. Nyctohemeral changes in bone turnover assessed by serum bone Gla-protein concentration and urinary deoxypyridinoline excretion: effects of growth and ageing. Clin Sci 1992;83:375-82.
142. Wichers M, Schmidt E, Bidlingmaier F, Klingmuller D. Diurnal rhythm of CrossLaps in human serum. Clin Chem 1999;45:1858-60.
143. Hassager C, Risteli J, Risteli L, Jensen SB, Christiansen C. Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal women. J Bone Miner Res 1992;7:1307-11.
144. Douglas AS, Miller MH, Reid DM, Hutchison JD, Porter RW, Robins SP. Seasonal differences in biochemical parameters of bone remodelling. J Clin Pathol 1996;49:284-9.
145. Thomsen K, Eriksen EF, Jorgensen JC, Charles P, Mosekilde L. Seasonal variation of serum bone GLA protein. Scand J Clin Lab Invest 1989;49:605-11.
146. Woitge HW, Scheidt-Nave C, Kissling C, Leidig-Bruckner G, Meyer K, Grauer A, et al. Seasonal variation of biochemical indexes of bone turnover: results of a population-based study. J Clin Endocrinol Metab 1998;83:68-75.
147. Woitge HW, Friedmann B, Suttner S, Farahmand I, Muller M, Schmidt-Gayk H, et al. Changes in bone turnover induced by aerobic and anaerobic exercise in young males. J Bone Miner Res 1998;13:1797-804.
148. Nishiyama S, Tomoeda S, Ohta T, Higuchi A, Matsuda I. Differences in basal and postexercise osteocalcin levels in athletic and nonathletic humans. Calcif Tissue Int 1988;43:150-4.
149. Welsh L, Rutherford OM, James I, Crowley C, Comer M, Wolman R. The acute effects of exercise on bone turnover. Int J Sports Med 1997;18:247-51.
150. Rudberg A, Magnusson P, Larsson L, Joborn H. Serum isoforms of bone alkaline phosphatase increase during physical exercise in women. Calcif Tissue Int 2000;66:342-7.
151. Ashizawa N, Ouchi G, Fujimura R, Yoshida Y, Tokuyama K, Suzuki M. Effects of a single bout of resistance exercise on calcium and bone metabolism in untrained young males. Calcif Tissue Int 1998;62:104-8.
152. Brahm H, Piehl-Aulin K, Ljunghall S. Biochemical markers of bone metabolism during distance running in healthy, regularly exercising men and women. Scand J Med Sci Sports 1996;6:26-30.
153. Jurimae J, Purge P, Jurimae T, Von Duvillard SP. Bone metabolism in elite male rowers: adaptation to volume-extended training. Eur J Appl Physiol 2006;97:127-32.
154. Shibata Y, Ohsawa I, Watanabe T, Miura T, Sato Y. Effects of physical training on bone mineral density and bone metabolism. J Physiol Anthropol Appl Human Sci 2003;22:203-8.
155. Maimoun L, Galy O, Manetta J, Coste O, Peruchon E, Micallef JP, et al. Competitive season of triathlon does not alter bone metabolism and bone mineral status in male triathletes. Int J Sports Med 2004;25:230-4.
156. Whipple TJ, Le BH, Demers LM, Chinchilli VM, Petit MA, Sharkey N, et al. Acute effects of moderate intensity resistance exercise on bone cell activity. Int J Sports Med 2004;25:496-501.
157. Thorsen K, Kristoffersson A, Hultdin J, Lorentzon R. Effects of moderate endurance exercise on calcium, parathyroid hormone, and markers of bone metabolism in young women. Calcif Tissue Int 1997;60:16-20.
158. Lippi G, Schena F, Montagnana M, Salvagno GL, Banfi G, Guidi GC. Acute variation of osteocalcin and parathyroid hormone in athletes after running a half-marathon. Clin Chem 2008;54:1093-5.
159. Kristoffersson A, Hultdin J, Holmlund I, Thorsen K, Lorentzon R. Effects of short-term maximal work on plasma calcium, parathyroid hormone, osteocalcin and biochemical markers of collagen metabolism. Int J Sports Med 1995;16:145-9.
160. Herrmann M, Muller M, Scharhag J, Sand-Hill M, Kindermann W, Herrmann W. The effect of endurance exercise-induced lac-tacidosis on biochemical markers of bone turnover. Clin Chem Lab Med 2007;45:1381-9.
161. Malm HT, Ronni-Sivula HM, Viinikka LU, Ylikorkala OR. Marathon running accompanied by transient decreases in urinary calcium and serum osteocalcin levels. Calcif Tissue Int 1993;52:209-11.
162. Herrmann M, Herrmann W. The assessment of bone metabolism in female elite endurance athletes by biochemical bone markers. Clin Chem Lab Med 2004;42:1384-9.
163. Larson-Meyer DE, Willis KS. Vitamin D and athletes. Curr Sports Med Rep 2010;9:220-6.
164. Bennell KL, Malcolm SA, Khan KM, Thomas SA, Reid SJ, Brukner PD, et al. Bone mass and bone turnover in power athletes, endurance athletes, and controls: a 12-month longitudinal study. Bone 1997;20:477-84.
165. Matsumoto T, Nakagawa S, Nishida S, Hirota R. Bone density and bone metabolic markers in active collegiate athletes: find-ings in long-distance runners, judoists, and swimmers. Int J Sports Med 1997;18:408-12.
166. Vasikaran SD, Cooper C, Kanis JA. Recommendations for bone marker standards in osteoporosis: what, why and where to now ? Ann Clin Biochem 2011;48:91-2.